Latest News-Ascletis Pharma Inc. Mediaroom_Page

* HBsAg reduction was observed in the 1 mg/kg ASC22 once every two weeks plus nucleos(t)ide analo...

2021-07-28 08:30 3532

HANGZHOU, China and SHAOXING, China, July 22, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code:...

2021-07-22 08:30 3736

--This bridging study to select doses for the Phase II trial in China in patients with chronic hep...

2021-07-13 08:30 3628

SHANGHAI, June 16, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKE...

2021-06-16 21:00 3947

HANGZHOU, China and SHAOXING, China, June 7, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672)...

2021-06-07 08:30 4080

SHANGHAI, May 27, 2021 /PRNewswire/ -- Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX...

2021-05-27 08:30 3792

HANGZHOU and SHAOXING, China, May 25, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) t...

2021-05-25 08:30 3736

HANGZHOU and SHAOXING, China, May 5, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672) toda...

2021-05-05 08:30 3985